Rare Disease Trials: To Placebo or Not to Placebo?
Time: 11:00 am
day: Clinical - AM
Details:
- Key considerations when considering incorporating a placebo control
- Outlining the implications to the sponsor, regulators, and patients
- When is a placebo considered unethical or unfeasible?
- How are global regulators’ attitudes on placebo control arms evolving?